One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

New drug target for asthma

Published on 13 October, 2016

A new therapeutic target for inflammatory diseases such as asthma and autoimmune disorders has been identified by scientists at the Wellcome Trust Sanger Institute. The researchers found that the PD-1 protein is a marker for developing Innate Lymphoid Cells that can trigger asthma.The LMB’s Andrew McKenzie is a author on the paper, and comments on this latest development. More…